NCT04224467 - The Application of Real-Time Near-infrared Imaging in Gynecological Surgery | Biotech Hunter

Enrollment

500

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

November 30, 2024

Study Completion Date

November 30, 2024

Conditions

Cervical CancerOvarian TumorEndometrial CarcinomaUterine MyomatosisAdenomyosisOvarian Cyst BenignOvarian Cyst MalignantEndometriosisUterine Sarcoma

Interventions

OTHER

Intravenous ICG and Real-Time Near-infrared Imaging

Patients will be intravenously injected ICG (Yichuang Pharmaceutical Limited Liability Company, Dandong, China) at a dose of 2-5 mg per kg of body weight before surgery or 0.25-0.5 mg per kg of body weight during surgery. Then real-time near-infrared imaging will be conducted during surgery.

Trial Locations (1)

510515

RECRUITING

Southern Medical Universtity, China, Guangzhou